Ledger.Open graph →

SEC Form D · Amendment · filed November 20, 2014

X2 Biosystems, Inc

Offering

$9.0M

Sold

$4.2M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SEATTLE, WA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

John G. Ralston · Seattle, WAExec · Director Richard Able · Seattle, WAExec · Director Robert G. Rosen · Seattle, WADirector Chris G. Siege · Seattle, WADirector Southlake Resources Group L.L.C · Fort Worth, TXExec · Director Brian Valentine · Bellevue, WAExec · Director Jonathan Alford · Redmond, WAExec · Director Richard J. Roberts · McLean, VAExec · Director Robert Sharpe · Burlingame, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗